Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs TAC Protocol (TAC) Price & Performance

InjectiveTrade
TAC ProtocolTrade

Price performance (Past 24H)

Key statistics

Injective vs TAC Protocol — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,78T 24h volume), while TAC Protocol trades at Rp55.42 (market cap Rp271,49M, Rp107,04M 24h volume). The key difference: Injective is far larger — about 34218.6× TAC Protocol's market cap, and Injective's circulating supply is 100M INJ versus 4,8B TAC for TAC Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and TAC Protocol for 4 Days on average.

INJTAC
Market Cap
Rp9,29TRp271,49M
Volume (24h)
Rp1,78TRp107,04M
Circulating Supply
100M INJ4,8B TAC
Typical Hold Time
36 Days4 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

TAC Protocol

TAC Protocol trades at Rp55.268 with a market cap of Rp267.36M, showing a bearish technical signal overall. The asset's hold time is 4 days, and moving averages indicate strong selling pressure. RSI levels show mixed signals, with RSI_12 at 9.90 suggesting potential oversold conditions. Support levels are at Rp40, Rp44, and Rp48, while resistance lies at Rp56, Rp60, and Rp64. No major protocol updates or ecosystem developments were noted in recent crypto-specific news.

The outlook remains cautious due to bearish technical indicators and low market cap, which may increase volatility. Key opportunities include potential rebounds from oversold RSI levels near support zones. Major risks involve low liquidity, regulatory uncertainty for cryptocurrencies, and limited on-chain activity. Investors should monitor for any upcoming protocol announcements or exchange listings that could impact price action.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
TAC
57% Buy43% Sell
Avg holding period · 4 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About TAC Protocol

TAC is the first EVM-compatible blockchain built specifically for the TON ecosystem and Telegram. It delivers full DeFi functionality from day one with EVM infrastructure, pre-deployed blue-chip DeFi apps, and liquidity from Ethereum and BTC.

Read more on TAC